These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 12556962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Famenini S, Martires KJ, Zhou H, Xavier MF, Wu JJ.
    J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
    [Abstract] [Full Text] [Related]

  • 5. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J, Frisch M, Yuen J, Glimelius B, Melbye M.
    BMJ; 1995 Jun 10; 310(6993):1491-5. PubMed ID: 7787593
    [Abstract] [Full Text] [Related]

  • 6. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden.
    Adami J, Gridley G, Nyrén O, Dosemeci M, Linet M, Glimelius B, Ekbom A, Zahm SH.
    Int J Cancer; 1999 Mar 01; 80(5):641-5. PubMed ID: 10048959
    [Abstract] [Full Text] [Related]

  • 7. A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma.
    Tsao H, Kwitkiwski K, Sober AJ.
    J Am Acad Dermatol; 2002 Jan 01; 46(1):55-61. PubMed ID: 11756946
    [Abstract] [Full Text] [Related]

  • 8. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
    Brewer JD, Shanafelt TD, Otley CC, Roenigk RK, Cerhan JR, Kay NE, Weaver AL, Call TG.
    J Clin Oncol; 2012 Mar 10; 30(8):843-9. PubMed ID: 22331952
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF.
    J Clin Oncol; 2010 Nov 20; 28(33):4935-44. PubMed ID: 20940199
    [Abstract] [Full Text] [Related]

  • 11. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM.
    J Clin Oncol; 2015 Oct 01; 33(28):3096-104. PubMed ID: 26240221
    [Abstract] [Full Text] [Related]

  • 12. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
    Goggins WB, Finkelstein DM, Tsao H.
    Cancer; 2001 Feb 15; 91(4):874-80. PubMed ID: 11241258
    [Abstract] [Full Text] [Related]

  • 13. Pigmentary traits, sun exposure, and risk of non-Hodgkin's lymphoma/chronic lymphocytic leukemia: A study within the French E3N prospective cohort.
    Garcin LM, Gelot A, Gomez RR, Gusto G, Boutron-Ruault MC, Kvaskoff M, Severi G, Besson C.
    Cancer Med; 2021 Jan 15; 10(1):297-304. PubMed ID: 33219744
    [Abstract] [Full Text] [Related]

  • 14. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
    Reyes C, Engel-Nitz NM, DaCosta Byfield S, Ravelo A, Ogale S, Bancroft T, Anderson A, Chen M, Matasar M.
    Oncologist; 2019 Sep 15; 24(9):1219-1228. PubMed ID: 30808814
    [Abstract] [Full Text] [Related]

  • 15. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW, Weaver AL, Shanafelt TD, Habermann TM, Wriston CC, Cerhan JR, Call TG, Brewer JD.
    Int J Dermatol; 2017 Nov 15; 56(11):1125-1129. PubMed ID: 28685851
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H, Kadri AN, Hernandez AV.
    Hematol Oncol; 2019 Aug 15; 37(3):261-269. PubMed ID: 30916804
    [Abstract] [Full Text] [Related]

  • 17. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL, Figgitt DP.
    Drugs; 2003 Aug 15; 63(8):803-43. PubMed ID: 12662126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T, Liphshitz I, Silverman B, Polliack A.
    Hematol Oncol; 2017 Dec 15; 35(4):599-607. PubMed ID: 27238496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.